UroGen Pharma (URGN) Invested Capital (2021 - 2026)
UroGen Pharma (URGN) reported Invested Capital of $56.34 million for Q2 2026, up 93.4% from $29.13 million a year earlier but down 13.7% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Invested Capital (2021 - 2026) Analysis & Trends
For FY2025, UroGen Pharma posted Invested Capital of $16.74 million, down 85.2% from FY2024.
- Invested Capital has a four-year compound annual growth rate of 18.8% (FY2021 to FY2025).
- By year, Invested Capital came in at $112.93 million in FY2024 (+238.7%), $33.34 million in FY2023 (+307.8%), $8.18 million in FY2022 (-2.8%) and $8.41 million in FY2021.
- Five-year quarterly Invested Capital spans a low of -$40.14 million in Q2 2023 and a high of $147.22 million in Q3 2024.
- Year over year, Invested Capital gained in four of the last eight quarters, with growth averaging 31.6%.
- The high point for year-over-year Invested Capital in five years was Q3 2023 (growth of 558.5%); the low point was Q3 2025 (a decline of 95.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $65.28 million (Q1 2026), $16.74 million (Q4 2025) and $6.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 148.69 Bn |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn | 56.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.34 Mn |
| Mar 31, 2026 | 65.28 Mn |
| Dec 31, 2025 | 16.74 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 29.13 Mn |
| Mar 31, 2025 | 75.65 Mn |
| Dec 31, 2024 | 112.93 Mn |
| Sep 30, 2024 | 147.22 Mn |
| Jun 30, 2024 | 128.13 Mn |
| Mar 31, 2024 | 57.46 Mn |
| Dec 31, 2023 | 33.34 Mn |
| Sep 30, 2023 | 56.53 Mn |
| Jun 30, 2023 | -40.14 Mn |
| Mar 31, 2023 | -18.61 Mn |
| Dec 31, 2022 | 8.18 Mn |
| Sep 30, 2022 | 8.58 Mn |
| Jun 30, 2022 | 30.28 Mn |
| Mar 31, 2022 | 53.72 Mn |
| Dec 31, 2021 | 8.41 Mn |
API Access
UroGen Pharma Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();